YU14302A - Veterinarska formulacija za davanje vodo-nerastvornih lekova željenoj životinji kroz sistem za distribuciju vode - Google Patents

Veterinarska formulacija za davanje vodo-nerastvornih lekova željenoj životinji kroz sistem za distribuciju vode

Info

Publication number
YU14302A
YU14302A YU14302A YUP14302A YU14302A YU 14302 A YU14302 A YU 14302A YU 14302 A YU14302 A YU 14302A YU P14302 A YUP14302 A YU P14302A YU 14302 A YU14302 A YU 14302A
Authority
YU
Yugoslavia
Prior art keywords
water
distribution system
water distribution
administration
target animal
Prior art date
Application number
YU14302A
Other languages
English (en)
Inventor
Peter Frank Ekhart
Mario Van Wendelen
Jan Matthijs Jetten
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of YU14302A publication Critical patent/YU14302A/sh
Publication of RS50341B publication Critical patent/RS50341B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Ovaj pronalazak se odnosi na postupak dobijanja formulacije suspoemulzije, koja se može lako proizvesti na industrijskoj skali i koja omogućava reproduktibilnost i efektivno davanje jednog ili više veterinarskih lekova nerastvornih u vodi, u finalnom obliku, je dispergovan u tečnosti koja se ne meša sa vodom, a zatim sledi homogenizacija ovog sistema u vodenu fazu. Da bi se olakšalo dobijanje stabilne formulacije, mogu se koristiti jedno ili više sredstava za stabilizaciju kao što su sredstva za emulgovanje, sredstva za zgušnjavanje, anti-oksidansi i antimikrobna sredstva. Rezultujuća suspoemulzija pokazuje odličnu stabilnost pri dugom skladištenju i dobru stabilnost "pri upotrebi" posle razblaživanja u sudu i u toku rukovanja i transporta u sistem za distribuciju vode.[This invention concerns a method for the preparation of a suspoemulsion formulation, which can be easily produced on an industrial scale and which allows the reproducible and effective administration of one or more water-insoluble veterinary drugs through water distribution systems. The water-insoluble veterinary drug, in finely ground form, is dispersed in a water immiscible liquid, followed by homogenisation of this system into a water phase. To facilitate the preparation of a stable formulation, one or more stabilising agents such as emulsifiers, thickeners, anti-oxidants and anti-microblals can be used. The resulting suspoemulsion shows excellent long term storage stability and a good "in use" stability after dilution in a vessel and during all handling and transport in the water distribution system.
YUP-143/02A 1999-09-03 2000-08-28 Veterinarska formulacija za davanje vodo-nerastvornih lekova željenoj životinji kroz sistem za distribuciju vode RS50341B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99202876 1999-09-03

Publications (2)

Publication Number Publication Date
YU14302A true YU14302A (sh) 2004-11-25
RS50341B RS50341B (sr) 2009-11-10

Family

ID=8240608

Country Status (35)

Country Link
US (1) US9040571B2 (sh)
EP (1) EP1214052B1 (sh)
JP (1) JP4754139B2 (sh)
KR (1) KR100702540B1 (sh)
CN (1) CN1165289C (sh)
AR (1) AR025470A1 (sh)
AT (1) ATE273000T1 (sh)
AU (1) AU775216B2 (sh)
BG (1) BG65673B1 (sh)
BR (1) BR0013754A (sh)
CA (1) CA2383164C (sh)
CZ (1) CZ301938B6 (sh)
DE (1) DE60012947T2 (sh)
EA (1) EA004785B1 (sh)
EE (1) EE05052B1 (sh)
ES (1) ES2226914T3 (sh)
HK (1) HK1049628B (sh)
HR (1) HRP20020173B1 (sh)
HU (1) HU229311B1 (sh)
IL (2) IL148438A0 (sh)
MA (1) MA25432A1 (sh)
ME (1) ME00132B (sh)
MX (1) MXPA02002360A (sh)
MY (1) MY128072A (sh)
NZ (1) NZ517024A (sh)
PL (1) PL201484B1 (sh)
PT (1) PT1214052E (sh)
RS (1) RS50341B (sh)
SI (1) SI1214052T1 (sh)
SK (1) SK285825B6 (sh)
TR (1) TR200200532T2 (sh)
TW (1) TWI234468B (sh)
UA (1) UA72933C2 (sh)
WO (1) WO2001017504A1 (sh)
ZA (1) ZA200201708B (sh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038022A1 (en) * 2001-03-26 2005-02-17 Unisearch Limited Method for treatment of cancer and compositions for use therein
CA2616512A1 (en) 2005-07-28 2007-02-08 Intervet International B.V. Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof
EP2037914B1 (en) 2006-06-14 2013-10-23 Intervet International BV A suspension comprising benzimidazole carbamate and a polysorbate
AR077320A1 (es) 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
EP2409683A1 (en) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Stable aqueous formulations comprising poorly water soluble active ingredients
RU2522267C2 (ru) * 2012-08-28 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
RU2522229C1 (ru) * 2013-03-26 2014-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Юго-Западный государственный университет" (ЮЗ ГУ) Способ инкапсуляции фенбендазола
RU2545742C2 (ru) * 2013-07-23 2015-04-10 Александр Александрович Кролевец Способ инкапсуляции лактобифадола
RU2555782C1 (ru) * 2014-03-03 2015-07-10 Александр Александрович Кролевец Способ получения нанокапсул сульфата глюкозамина в конжаковой камеди в гексане
RU2555055C1 (ru) * 2014-03-18 2015-07-10 Александр Александрович Кролевец Способ получения нанокапсул сульфата глюкозамина в ксантановой камеди
RU2558084C1 (ru) * 2014-03-18 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул аспирина в каррагинане
RU2557941C1 (ru) * 2014-03-20 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул аспирина в альгинате натрия
RU2554759C1 (ru) * 2014-04-07 2015-06-27 Александр Александрович Кролевец Способ получения нанокапсул лозартана калия
ES2925656T3 (es) * 2016-04-29 2022-10-19 Rousselot B V Excipiente basado en proteínas para principios farmacéuticos activos
CN110151692A (zh) * 2019-06-21 2019-08-23 石家庄九鼎动物药业有限公司 一种兽用抗寄生虫药物阿苯达唑混悬液制备方法
CN110693830B (zh) * 2019-10-10 2021-09-17 华中农业大学 一种兽用奥芬达唑纳米混悬液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
US5538989A (en) * 1993-11-10 1996-07-23 Hoechst-Roussel Agri-Vet Company Fenbendazole formulations
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions

Also Published As

Publication number Publication date
SK285825B6 (sk) 2007-09-06
EP1214052B1 (en) 2004-08-11
ZA200201708B (en) 2003-08-27
MEP9108A (en) 2010-06-10
EE200200094A (et) 2003-04-15
ATE273000T1 (de) 2004-08-15
DE60012947D1 (de) 2004-09-16
MA25432A1 (fr) 2002-04-01
CA2383164C (en) 2008-07-08
AR025470A1 (es) 2002-11-27
HRP20020173A2 (en) 2004-04-30
EA200200325A1 (ru) 2002-08-29
IL148438A (en) 2006-12-10
HRP20020173B1 (en) 2005-02-28
PT1214052E (pt) 2004-12-31
BG65673B1 (bg) 2009-06-30
WO2001017504A1 (en) 2001-03-15
US20090062362A1 (en) 2009-03-05
RS50341B (sr) 2009-11-10
HUP0202686A3 (en) 2004-06-28
EE05052B1 (et) 2008-08-15
EP1214052A1 (en) 2002-06-19
DE60012947T2 (de) 2005-08-25
PL353481A1 (en) 2003-11-17
SI1214052T1 (en) 2005-02-28
HUP0202686A2 (hu) 2004-05-28
AU775216B2 (en) 2004-07-22
KR100702540B1 (ko) 2007-04-04
TR200200532T2 (tr) 2002-07-22
ME00132B (me) 2010-10-10
JP2003508482A (ja) 2003-03-04
BG106448A (en) 2002-09-30
SK2642002A3 (en) 2002-12-03
MY128072A (en) 2007-01-31
TWI234468B (en) 2005-06-21
PL201484B1 (pl) 2009-04-30
KR20020063844A (ko) 2002-08-05
MXPA02002360A (es) 2002-07-30
BR0013754A (pt) 2002-05-21
HK1049628A1 (en) 2003-05-23
CZ2002630A3 (cs) 2002-09-11
CA2383164A1 (en) 2001-03-15
CZ301938B6 (cs) 2010-08-04
US9040571B2 (en) 2015-05-26
EA004785B1 (ru) 2004-08-26
AU7322900A (en) 2001-04-10
CN1372462A (zh) 2002-10-02
NZ517024A (en) 2003-05-30
HU229311B1 (en) 2013-10-28
IL148438A0 (en) 2002-09-12
CN1165289C (zh) 2004-09-08
UA72933C2 (uk) 2005-05-16
ES2226914T3 (es) 2005-04-01
JP4754139B2 (ja) 2011-08-24
HK1049628B (zh) 2005-05-13

Similar Documents

Publication Publication Date Title
YU14302A (sh) Veterinarska formulacija za davanje vodo-nerastvornih lekova željenoj životinji kroz sistem za distribuciju vode
DK278288D0 (da) Frigivelsessystem til laegemiddel ved anvendelse i mundhulen og en fremgangsmaade til fremstilling af dette frigivelsesystem
US4096262A (en) Pour-on anthelmintics
AR007715A1 (es) Formulacion acuosa estable de un peptido, un metodo para preparar la misma y su uso para tratamiento
DE69106501T2 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
DE69428040T2 (de) Orale darreichungsform
PT928182E (pt) Sistema de distribuicao para produtos farmaceuticos embalados em frascos farmaceuticos
EP1464222A2 (en) Hydroalcoholic compositions thickened using surfactant/polymer complexes
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
WO1994009625A3 (en) Stabilization of fluorocarbon emulsions
DK0950403T3 (da) Emulsioner til in-situ leveringssystemer
ES2114851T3 (es) Utilizacion de composiciones de liberacion sostenida que contienen gnrh, lhrh o derivados de las mismas.
ES2017265A6 (es) Formulaciones de tabletas de pesticidas.
AU4949993A (en) Drugs containing diphosphonic acids and salts thereof
ES2186207T3 (es) Metodo para preparacion de formulaciones farmaceuticas.
IT1226940B (it) Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
MY106540A (en) Gel formulations for use in toxic or hazardous product containerization systems.
ES2053528T3 (es) Composicion farmaceutica que comprende un medicamento y un polimero hinchable en agua.
IE791454L (en) Medicinal formulation
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem
NZ333656A (en) Liquid formulation comprising less 5% w/w saturated polyglycosylated C8-10 glycerides (capryl caproyl macrogol glycerides) and a non-peptide for oro-mucosal administration
CN110051687A (zh) 一种防滴型聚维酮碘消毒浸剂及其制备方法和应用
Zaneveld et al. Nonhormonal mediation of male reproductive tract damage: data from contraceptive drug research
FR2699088B1 (fr) Dispositif d'extraction en continu des principes actifs contenus dans des matières végétales, animales ou minérales.
TH14574A (th) สารผสมทางเภสัชกรรม